Next Article in Journal
Antidiabetic Properties of Naringenin: A Citrus Fruit Polyphenol
Next Article in Special Issue
In Vitro Interactions of Moroccan Propolis Phytochemical’s on Human Tumor Cell Lines and Anti-Inflammatory Properties
Previous Article in Journal
The Relationship between Epicardial Adipose Tissue Thickness and Serum Interleukin-17a Level in Patients with Isolated Metabolic Syndrome
Previous Article in Special Issue
Combination Anthelmintic/Antioxidant Activity Against Schistosoma Mansoni
Open AccessArticle

The Main Metabolites of Fluorouracil + Adriamycin + Cyclophosphamide (FAC) Are Not Major Contributors to FAC Toxicity in H9c2 Cardiac Differentiated Cells

1
UCIBIO, REQUIMTE, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal
2
Laboratory of Organic and Pharmaceutical Chemistry, Department of Chemistry, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal
3
CIIMAR–Interdisciplinary Centre of Marine and Environmental Research, 4450-208 Porto, Portugal
*
Authors to whom correspondence should be addressed.
Biomolecules 2019, 9(3), 98; https://doi.org/10.3390/biom9030098
Received: 11 January 2019 / Revised: 21 February 2019 / Accepted: 1 March 2019 / Published: 11 March 2019
(This article belongs to the Special Issue Multidrug Combinations)
In the clinical practice, the combination of 5-fluorouracil (5-FU) + Adriamycin (also known as doxorubicin, DOX) + cyclophosphamide (CYA) (known as FAC) is used to treat breast cancer. The FAC therapy, however, carries some serious risks, namely potential cardiotoxic effects, although the mechanisms are still unclear. In the present study, the role of the main metabolites regarding FAC-induced cardiotoxicity was assessed at clinical relevant concentrations. Seven-day differentiated H9c2 cells were exposed for 48 h to the main metabolites of FAC, namely the metabolite of 5-FU, α-fluoro-β-alanine (FBAL, 50 or 100 μM), of DOX, doxorubicinol (DOXOL, 0.2 or 1 μM), and of CYA, acrolein (ACRO, 1 or 10 μM), as well as to their combination. The parent drugs (5-FU 50 μM, DOX 1 μM, and CYA 50 μM) were also tested isolated or in combination with the metabolites. Putative cytotoxicity was evaluated through phase contrast microscopy, Hoechst staining, membrane mitochondrial potential, and by two cytotoxicity assays: the reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) and the neutral red (NR) lysosomal incorporation. The metabolite DOXOL was more toxic than FBAL and ACRO in the MTT and NR assays. When in combination, neither FBAL nor ACRO increased DOXOL-induced cytotoxicity. No nuclear condensation was observed for any of the tested combinations; however, a significant mitochondrial potential depolarization after FBAL 100 μM + DOXOL 1 μM + ACRO 10 μM or FBAL 100 μM + DOXOL 1 μM exposure was seen at 48 h. When tested alone DOX 1 μM was more cytotoxic than all the parent drugs and metabolites in both the cytotoxicity assays performed. These results demonstrated that DOXOL was the most toxic of all the metabolites tested; nonetheless, the metabolites do not seem to be the major contributors to FAC-induced cardiotoxicity in this cardiac model. View Full-Text
Keywords: doxorubicinol; fluoro-β-alanine; acrolein; cardiotoxicity; differentiated H9c2 cells doxorubicinol; fluoro-β-alanine; acrolein; cardiotoxicity; differentiated H9c2 cells
Show Figures

Figure 1

MDPI and ACS Style

Reis-Mendes, A.; Carvalho, F.; Remião, F.; Sousa, E.; Bastos, M.d.L.; Costa, V.M. The Main Metabolites of Fluorouracil + Adriamycin + Cyclophosphamide (FAC) Are Not Major Contributors to FAC Toxicity in H9c2 Cardiac Differentiated Cells. Biomolecules 2019, 9, 98. https://doi.org/10.3390/biom9030098

AMA Style

Reis-Mendes A, Carvalho F, Remião F, Sousa E, Bastos MdL, Costa VM. The Main Metabolites of Fluorouracil + Adriamycin + Cyclophosphamide (FAC) Are Not Major Contributors to FAC Toxicity in H9c2 Cardiac Differentiated Cells. Biomolecules. 2019; 9(3):98. https://doi.org/10.3390/biom9030098

Chicago/Turabian Style

Reis-Mendes, Ana; Carvalho, Félix; Remião, Fernando; Sousa, Emília; Bastos, Maria d.L.; Costa, Vera M. 2019. "The Main Metabolites of Fluorouracil + Adriamycin + Cyclophosphamide (FAC) Are Not Major Contributors to FAC Toxicity in H9c2 Cardiac Differentiated Cells" Biomolecules 9, no. 3: 98. https://doi.org/10.3390/biom9030098

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop